106 related articles for article (PubMed ID: 2124219)
1. Evaluation of the interaction of lithium and alprazolam.
Evans RL; Nelson MV; Melethil S; Townsend R; Hornstra RK; Smith RB
J Clin Psychopharmacol; 1990 Oct; 10(5):355-9. PubMed ID: 2124219
[TBL] [Abstract][Full Text] [Related]
2. Effect of venlafaxine on the pharmacokinetics of alprazolam.
Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
Psychopharmacol Bull; 1998; 34(2):211-9. PubMed ID: 9641003
[TBL] [Abstract][Full Text] [Related]
3. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.
Labbate LA; Pollack MH; Otto MW; Tesar GM; Rosenbaum JF
J Clin Psychopharmacol; 1994 Aug; 14(4):274-6. PubMed ID: 7962684
[TBL] [Abstract][Full Text] [Related]
4. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
Miljković BR; Pokrajac M; Timotijević I; Varagić V
Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
[TBL] [Abstract][Full Text] [Related]
5. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
Smith RB; Gwilt PR; Wright CE
Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
[TBL] [Abstract][Full Text] [Related]
6. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
Marr MA; Djuric PE; Ritschel WA; Garver DL
Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers.
Breuel HP; Müller-Oerlinghausen B; Nickelsen T; Heine PR
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):415-9. PubMed ID: 7582400
[TBL] [Abstract][Full Text] [Related]
8. The effect of flurbiprofen on steady-state plasma lithium levels.
Hughes BM; Small RE; Brink D; McKenzie ND
Pharmacotherapy; 1997; 17(1):113-20. PubMed ID: 9017771
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin.
Hamzeh FM; Benson C; Gerber J; Currier J; McCrea J; Deutsch P; Ruan P; Wu H; Lee J; Flexner C;
Clin Pharmacol Ther; 2003 Mar; 73(3):159-69. PubMed ID: 12621381
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of lithium-nonsteroidal anti-inflammatory drug interactions.
Ragheb M
J Clin Psychopharmacol; 1990 Oct; 10(5):350-4. PubMed ID: 2258452
[TBL] [Abstract][Full Text] [Related]
11. Alprazolam kinetics following sublingual and oral administration.
Scavone JM; Greenblatt DJ; Shader RI
J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
[TBL] [Abstract][Full Text] [Related]
13. Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine.
Lau CE; Wang Y; Falk JL
J Pharmacol Exp Ther; 1997 Jun; 281(3):1013-29. PubMed ID: 9190832
[TBL] [Abstract][Full Text] [Related]
14. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
15. [Initiating thymoregulator treatment].
Olié JP; Launay C; Poirier MF
Encephale; 1995 Mar; 21 Spec No 2():71-8. PubMed ID: 7588183
[TBL] [Abstract][Full Text] [Related]
16. An overview of the pharmacology of intravenously administered ciprofloxacin.
Drusano GL
Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
[TBL] [Abstract][Full Text] [Related]
17. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of lithium in the elderly.
Hardy BG; Shulman KI; Mackenzie SE; Kutcher SP; Silverberg JD
J Clin Psychopharmacol; 1987 Jun; 7(3):153-8. PubMed ID: 3110219
[TBL] [Abstract][Full Text] [Related]
19. [Renal clearance technic for individualizing lithium dosage in routine hospital care].
Klinger E; Steimer JL; Jouvent R; Le Moël G; Mascart JY; Des Lauriers A
Encephale; 1984; 10(5):223-30. PubMed ID: 6440774
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
Greenblatt DJ; Wright CE
Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]